MASTOCYTIC LEUKAEMIA

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting MASTOCYTIC LEUKAEMIA:

# Drug Count
0 RYDAPT 3
1 AZACITIDINE 2
2 BISOPROLOL FUMARATE 2
3 CETIIRIZINE 2
4 CETIRIZINE 2
5 CETIRIZINE HYDROCHLORIDE 2
6 AXICABTAGENE CILOLEUCEL 1
7 BEVACIZUMAB 1
8 CARBOPLATIN 1
9 CLADRIBINE 1
See all common drugs associated with MASTOCYTIC LEUKAEMIA

MASTOCYTIC LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RYDAPT 3 0.0015
1 CLADRIBINE 1 0.0001
2 AXICABTAGENE CILOLEUCEL 1 0.0001
3 RANOLAZINE 1 0.0001
4 TOLVAPTAN 1 0.0001
5 AZACITIDINE 2 0.0001
6 CETIIRIZINE 2 0.0000
7 IMATINIB MESYLATE 1 0.0000
8 NILOTINIB 1 0.0000
9 HYDROXYZINE 1 0.0000
See all drugs enriched for association with MASTOCYTIC LEUKAEMIA